We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights ADMA Biologics, Northern Technologies, PlayAGS, Merchants Bank and Strategic Education
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 16, 2024 – Stocks in this week’s article are ADMA Biologics Inc. (ADMA - Free Report) , Northern Technologies International Corp. (NTIC - Free Report) , PlayAGS Inc. (AGS - Free Report) , Merchants Bancorp (MBIN - Free Report) and Strategic Education Inc. (STRA - Free Report) .
5 Stocks with Recent Price Strength to Tap May's Rally
The 15-month bull run of U.S. stock markets suffered a surprise setback in April. We believe that April’s meltdown was nothing but a bull market correction, and this time a welcome one, as Wall Street has rebounded in May.
The Department of Labor reported that the U.S. economy added 175,000 jobs in April, missing the consensus estimate of 200,000. Job additions in March were revised upward by 12,000 while those in February were revised downward by 34,000. The unemployment rate increased to 3.9% in April, compared with the consensus estimate and March’s data of 3.8%. April marked the highest level since January 2022.
Month over month, the average hourly earnings rate dropped to 0.2% in April, compared with the consensus estimate and March’s data of 0.3%. Year over year, the wage rate increased 3.9% in April but came in below the consensus estimate of 4%.
The Department of Commerce reported that U.S. GDP grew at a 1.6% annualized rate in first-quarter 2024, well below the consensus estimate of 2.5%. Moreover, the Institute of Supply Management (ISM) reported that both manufacturing and services PMIs (purchasing managers’ index) contracted in April.
The manufacturing PMI of April came in at 49.2% and that of services PMI was 49.4%. Any reading below 50% indicates a contraction in activities. The manufacturing PMI expanded in March after 16 consecutive months of contraction. It again contracted in April. The services PMI contracted in April after 15 successive months of expansion.
Following the release of April’s nonfarm payrolls, the CME FedWatch shows a 62.7% probability that the central bank will cut the benchmark lending rate by 25 basis points in the September FOMC meeting.
The interest rate futures tool also shows a massive 88.3% probability that the Fed will cut the rate by 50 basis points. Notably, the Fed fund rate has been within the range of 5.25-5.5% since July 2023.
As a result, a few stocks have shown price strength. We have selected five stocks likely to gain in the near term on the back of a favorable Zacks Rank. These companies are — ADMA Biologics Inc., Northern Technologies International Corp., PlayAGS Inc., Merchants Bancorp and Strategic Education Inc.
Here’s How We Arrived At the Picks
We have primarily targeted stocks that have freshly been on a bull run. Stocks seeing price strength recently have a high chance of carrying the momentum forward.
If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.
However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.
Here’s how you should create the screen to shortlist the current as well as the potential winners.
Let’s discuss five out of these six stocks:
ADMA Biologics is a specialty immune globulin company. ADMA develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases.
ADMA’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or may be immune-suppressed for medical reasons. ADMA’s lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease.
The stock price of ADMA Biologics has soared 46.4% in the past four weeks. It has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3.3% over the last seven days.
Northern Technologies develops and markets rust and corrosion-inhibiting solutions in North America, South America, Europe, Asia, the Middle East and internationally. NTIC provides a portfolio of bio-based and certified compostable polymer resin compounds and finished products under the Natur-Tec brand.
NTIC offers rust and corrosion-inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand.
The stock price of Northern Technologies has jumped 36.8% in the past four weeks. It has an expected earnings growth rate of more than 100% for the current year (ending August 2024). The Zacks Consensus Estimate for current-year earnings has improved 4% over the last 30 days.
PlayAGS designs and supplies gaming products and services for the gaming industry in the United States and internationally. AGS operates through three segments: Electronic Gaming Machines, Table Products, and Interactive Games.
AGS’ product line-up includes Class III EGMs for commercial and Native American casinos, video bingo machines for select international markets, table game products and interactive social casino products.
The stock price of PlayAGS has climbed 24.2% in the past four weeks. It has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 31.6% over the last seven days.
Merchants Bancorp operates as a diversified bank holding company in the United States. MBIN operates through three segments: Multi-family Mortgage Banking, Mortgage Warehousing, and Banking.
MBIN provides multi-family housing and health care facility financing, mortgage warehousing, retail and correspondent residential mortgage banking, agricultural lending and traditional community banking services, through its subsidiaries.
The stock price of Merchants Bancorp has surged 23.4% in the past four weeks. It has an expected earnings growth rate of 17% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 16.8% over the last 30 days.
Strategic Education provides education services through campus-based and online post-secondary education, and programs to develop job-ready skills. STRA operates through the U.S. Higher Education, Australia/New Zealand, and Education Technology Services segments.
STRA’s subsidiaries Strayer University and New York Code and Design Academy (NYCDA), provides a range of post-secondary education and other academic programs in the United States. NYCDA is a New York City-based provider of web and application software development courses.
The stock price of Strategic Education has advanced 22.7% in the past four weeks. STRA has an expected earnings growth rate of 32% for the current year. The Zacks Consensus Estimate for current-year earnings improved 6.7% over the last 30 days.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks.com featured highlights ADMA Biologics, Northern Technologies, PlayAGS, Merchants Bank and Strategic Education
For Immediate Release
Chicago, IL – May 16, 2024 – Stocks in this week’s article are ADMA Biologics Inc. (ADMA - Free Report) , Northern Technologies International Corp. (NTIC - Free Report) , PlayAGS Inc. (AGS - Free Report) , Merchants Bancorp (MBIN - Free Report) and Strategic Education Inc. (STRA - Free Report) .
5 Stocks with Recent Price Strength to Tap May's Rally
The 15-month bull run of U.S. stock markets suffered a surprise setback in April. We believe that April’s meltdown was nothing but a bull market correction, and this time a welcome one, as Wall Street has rebounded in May.
The Department of Labor reported that the U.S. economy added 175,000 jobs in April, missing the consensus estimate of 200,000. Job additions in March were revised upward by 12,000 while those in February were revised downward by 34,000. The unemployment rate increased to 3.9% in April, compared with the consensus estimate and March’s data of 3.8%. April marked the highest level since January 2022.
Month over month, the average hourly earnings rate dropped to 0.2% in April, compared with the consensus estimate and March’s data of 0.3%. Year over year, the wage rate increased 3.9% in April but came in below the consensus estimate of 4%.
The Department of Commerce reported that U.S. GDP grew at a 1.6% annualized rate in first-quarter 2024, well below the consensus estimate of 2.5%. Moreover, the Institute of Supply Management (ISM) reported that both manufacturing and services PMIs (purchasing managers’ index) contracted in April.
The manufacturing PMI of April came in at 49.2% and that of services PMI was 49.4%. Any reading below 50% indicates a contraction in activities. The manufacturing PMI expanded in March after 16 consecutive months of contraction. It again contracted in April. The services PMI contracted in April after 15 successive months of expansion.
Following the release of April’s nonfarm payrolls, the CME FedWatch shows a 62.7% probability that the central bank will cut the benchmark lending rate by 25 basis points in the September FOMC meeting.
The interest rate futures tool also shows a massive 88.3% probability that the Fed will cut the rate by 50 basis points. Notably, the Fed fund rate has been within the range of 5.25-5.5% since July 2023.
As a result, a few stocks have shown price strength. We have selected five stocks likely to gain in the near term on the back of a favorable Zacks Rank. These companies are — ADMA Biologics Inc., Northern Technologies International Corp., PlayAGS Inc., Merchants Bancorp and Strategic Education Inc.
Here’s How We Arrived At the Picks
We have primarily targeted stocks that have freshly been on a bull run. Stocks seeing price strength recently have a high chance of carrying the momentum forward.
If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.
However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.
Here’s how you should create the screen to shortlist the current as well as the potential winners.
Let’s discuss five out of these six stocks:
ADMA Biologics is a specialty immune globulin company. ADMA develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases.
ADMA’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or may be immune-suppressed for medical reasons. ADMA’s lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease.
The stock price of ADMA Biologics has soared 46.4% in the past four weeks. It has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3.3% over the last seven days.
Northern Technologies develops and markets rust and corrosion-inhibiting solutions in North America, South America, Europe, Asia, the Middle East and internationally. NTIC provides a portfolio of bio-based and certified compostable polymer resin compounds and finished products under the Natur-Tec brand.
NTIC offers rust and corrosion-inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand.
The stock price of Northern Technologies has jumped 36.8% in the past four weeks. It has an expected earnings growth rate of more than 100% for the current year (ending August 2024). The Zacks Consensus Estimate for current-year earnings has improved 4% over the last 30 days.
PlayAGS designs and supplies gaming products and services for the gaming industry in the United States and internationally. AGS operates through three segments: Electronic Gaming Machines, Table Products, and Interactive Games.
AGS’ product line-up includes Class III EGMs for commercial and Native American casinos, video bingo machines for select international markets, table game products and interactive social casino products.
The stock price of PlayAGS has climbed 24.2% in the past four weeks. It has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 31.6% over the last seven days.
Merchants Bancorp operates as a diversified bank holding company in the United States. MBIN operates through three segments: Multi-family Mortgage Banking, Mortgage Warehousing, and Banking.
MBIN provides multi-family housing and health care facility financing, mortgage warehousing, retail and correspondent residential mortgage banking, agricultural lending and traditional community banking services, through its subsidiaries.
The stock price of Merchants Bancorp has surged 23.4% in the past four weeks. It has an expected earnings growth rate of 17% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 16.8% over the last 30 days.
Strategic Education provides education services through campus-based and online post-secondary education, and programs to develop job-ready skills. STRA operates through the U.S. Higher Education, Australia/New Zealand, and Education Technology Services segments.
STRA’s subsidiaries Strayer University and New York Code and Design Academy (NYCDA), provides a range of post-secondary education and other academic programs in the United States. NYCDA is a New York City-based provider of web and application software development courses.
The stock price of Strategic Education has advanced 22.7% in the past four weeks. STRA has an expected earnings growth rate of 32% for the current year. The Zacks Consensus Estimate for current-year earnings improved 6.7% over the last 30 days.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2274005/5-stocks-with-recent-price-strength-to-tap-mays-rally
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.